Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies

• Prif Awduron: Emeka Eze Joshua Iweala (Awdur), Doris Nnenna Amuji (Awdur), Abimbola Mary Oluwajembola (Awdur), Eziuche Amadike Ugbogu (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2024-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Breast cancer presents a significant challenge due to its heterogeneity and propensity for developing chemoresistance, particularly in the triple-negative subtype. c-Mesenchymal epithelial transition factor (c-Met), a receptor tyrosine kinase, presents a promising target for breast cancer therapy du...